Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCα

Biochemical and Biophysical Research Communications

Volumn 349, Issue 4, 2006, Pages 1361-1367

  Jagadeesh, Shankar ^a   Banerjee, Partha P ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Akt; Inositol hexaphosphate; PKC; Prostate cancer; Telomerase; TERT

Indexed keywords

PHYTIC ACID; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL NUCLEUS TRANSPLANTATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MALE; MICE; PHYTIC ACID; PROSTATIC NEOPLASMS; PROTEIN KINASE C; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SPECIES SPECIFICITY; TELOMERASE;

EID: 33748776546     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.002     Document Type: Article

References (28)

1. Greider C.W., and Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43 (1985) 405-413
2. Kim N.W., Piatyszek M.A., Prowse K.R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
3. Harley C.B., and Villeponteau B. Telomeres and telomerase in aging and cancer. Curr. Opin. Genet. Dev. 5 (1995) 249-255
4. Cong Y.S., Wright W.E., and Shay J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66 (2002) 407-425
5. Stampfer M.R., and Yaswen P. Human epithelial cell immortalization as a step in carcinogenesis. Cancer Lett. 194 (2003) 199-208
6. Kang S.S., Kwon T., Kwon D.Y., and Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274 (1999) 13085-13090
7. Smith L.L., Coller H.A., and Roberts J.M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5 (2003) 474-479
8. Williams G.M., Williams C.L., and Weisburger J.H. Diet and cancer prevention: the fiber first diet. Toxicol. Sci. 52 (1999) 72-86
9. Shamsuddin A.M., Vucenik I., and Cole K.E. IP6: a novel anti-cancer agent. Life Sci. 61 (1997) 343-354
10. Sakamoto K., Venkatraman G., and Shamsuddin A.M. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). Carcinogenesis 14 (1993) 1815-1819
11. Vucenik I., Zhang Z.S., and Shamsuddin A.M. IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice. Anticancer Res. 18 (1998) 4091-4096
12. Huang C., Ma W.Y., Hecht S.S., and Dong Z. Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3' kinase. Cancer Res. 57 (1997) 2873-2878
13. Wattenberg L.W. Chemoprevention of pulmonary carcinogenesis by myo-inositol. Anticancer Res. 19 (1999) 3659-3661
14. Singh R.P., Agarwal C., and Agarwal R. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Carcinogenesis 24 (2003) 555-563
15. Saied I.T., and Shamsuddin A.M. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res. 18 (1998) 1479-1484
16. Singh R.P., Sharma G., Mallikarjuna G.U., Dhanalakshmi S., Agarwal C., and Agarwal R. In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Clin. Cancer Res. 10 (2004) 244-250
17. Jagadeesh S., Kyo S., and Banerjee P.P. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res. 66 (2006) 2107-2115
18. Zi X., Singh R.P., and Agarwal R. Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells. Carcinogenesis 21 (2000) 2225-2235
19. Kim Y.W., Hur S.Y., Kim T.E., et al. Protein kinase C modulates telomerase activity in human cervical cancer cells. Exp. Mol. Med. 33 (2001) 156-163
20. Liu K., Hodes R.J., and Weng N.P. Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J. Immunol. 166 (2001) 4826-4830
21. Seimiya H., Sawada H., Muramatsu Y., et al. Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J. 19 (2000) 2652-2661
22. Akiyama M., Hideshima T., Hayashi T., et al. Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res. 63 (2003) 18-21
23. Agarwal C., Dhanalakshmi S., Singh R.P., and Agarwal R. Inositol hexaphosphate inhibits constitutive activation of NF- kappa B in androgen-independent human prostate carcinoma DU145 cells. Anticancer Res. 23 (2003) 3855-3861
24. Wang J., Xie L.Y., Allan S., Beach D., and Hannon G.J. Myc activates telomerase. Genes Dev. 12 (1998) 1769-1774
25. Jagadeesh S., and Banerjee P.P. Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem. Biophys. Res. Commun. 347 (2006) 774-780
26. Arato-Ohshima T., and Sawa H. Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int. J. Cancer 83 (1999) 387-392
27. Shamsuddin A.M., and Ullah A. Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane. Carcinogenesis 10 (1989) 625-626
28. Vucenik I., Yang G.Y., and Shamsuddin A.M. Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis 16 (1995) 1055-1058